Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that it has entered into a Master Services Collaboration Agreement with ...

Patients 1 and 2 had bone marrow cytogenetic analyses and reverse transcriptase-polymerase chain reaction (RT-PCR) screening for chromosomal translocations performed at initial presentation ...

They found that mutant MLL proteins bind at different sites in myeloid and lymphoid lineage leukemias, underscoring how the lineage context can influence the genetic targets of mutant MLL proteins in ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, ...

Kura Oncology (NASDAQ:KURA – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings ...

Adults also have leukemias, but the most common childhood cancers are the leukemias. it is about the fourth commonest cancer ...

Kevin’s mind relied on familiar pathways built by years of playing and coaching basketball. He used his analytical skills to ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...

Cell and gene therapy tout promising results, but manufacturing challenges around personalized treatments require industry ...

Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment, is approaching a critical juncture in its development ...

While genetic screening is not a magic bullet, it has the potential to change the landscape of childhood cancer care in India ...